Pharmacia Limited

Ramsgate Road, Sandwich, Kent, CT13 9NJ
Telephone: +44 (0)1304 616 161
Fax: +44 (0)1304 656 221
Summary of Product Characteristics last updated on the eMC: 12/03/2004
SPC Caverject Powder for Injection 5, 10, 20, 40 Micrograms

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 12/03/2004 and displayed until Current
Reasons for adding or updating:
  • Change to section 7 - Marketing Authorisation Holder
Updated on 16/07/2003 and displayed until 12/03/2004
Reasons for adding or updating:
  • Change to section 1 - trade name
  • Change to section 2 - qualitative and quantitative composition
  • Change to section 3 - pharmaceutical form
  • Change to section 6.1 - List of Excipients
  • Change to section 6.2 - Incompatibilities
  • Change to section 6. 3 - Shelf Life
  • Change to section 6. 4 - Special Precautions for Storage
  • Change to section 4.2 - Posology and Method of Administration
  • Change to section 6. 5 - Nature and Contents of Container
  • Change to section 6. 6 - Instruction for Use/Handling
  • Change to section 10 (date of (partial) revision of the text
Updated on 23/08/2001 and displayed until 16/07/2003
Reasons for adding or updating:
  • Change to section 7 - Marketing Authorisation Holder
  • Change to section 10 (date of (partial) revision of the text
Updated on 20/08/2001 and displayed until 23/08/2001
Reasons for adding or updating:
  • Correction of spelling/typing errors
Updated on 13/07/2001 and displayed until 20/08/2001
Reasons for adding or updating:
  • Correction of spelling/typing errors
Updated on 06/09/1999 and displayed until 13/07/2001
Reasons for adding or updating:
  • No reasons supplied

Active Ingredients/Generics

 
   alprostadil


© 2010 Datapharm Communications Ltd

Go to www.medicines.org.uk